BlackRock Institutional Trust’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,849,556
Closed -$1.67B 4011
2014
Q4
$1.67B Sell
7,849,556
-10,993
-0.1% -$2.19M 0.27% 71
2014
Q3
$1.4B Sell
7,860,549
-961,902
-11% -$160M 0.24% 85
2014
Q2
$1.49B Buy
8,822,451
+962,321
+12% +$150M 0.25% 80
2014
Q1
$975M Buy
7,860,130
+183,936
+2% +$22.4M 0.17% 115
2013
Q4
$853M Sell
7,676,194
-1,012,156
-12% -$96.7M 0.15% 132
2013
Q3
$786M Sell
8,688,350
-931,736
-10% -$83.6M 0.15% 132
2013
Q2
$810M Buy
+9,620,086
New +$998M 0.16% 121

Other funds holding AGN

BlackRock Institutional Trust's AGN Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,849,556 shares — an estimated $1.67B sold.

BlackRock Institutional Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.67B in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock Institutional Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 7,849,556 Allergan Inc shares in Q1 2015, an estimated $1.67B.
  • BlackRock Institutional Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock Institutional Trust's Allergan Inc position peaked at $1.67B in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.